Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Chilean team presents new biomarker of gastric cancer progression

Jan. 20, 2012

MLN-8237 investigated with cisplatin in gastrointestinal cancer models

Jan. 20, 2012

Therapeutic investigation of dacomitinib expands to gastric cancer

Jan. 20, 2012

Tesetaxel is active in patients with gastroesophageal cancer

Jan. 20, 2012

BKM-120 assessed as monotherapy and in combination regimens in metastatic breast cancer

Jan. 11, 2012

New Evestra progesterone receptor inhibitor shows potential as breast cancer therapy

Jan. 10, 2012

Phase I/II data presented on SAR-245408-based combination regimens in metastatic breast cancer

Jan. 10, 2012

Ongoing phase I/II trial assesses combinations of letrozole with SAR-245408 and SAR-245409

Jan. 10, 2012

Phase I/II study evaluates rintatolimod as adjuvant for HER2 vaccine

Jan. 9, 2012

University of Arizona scientists assess natural monoterpene in phase I trial

Jan. 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...